Literature DB >> 2742277

Developmental consequences of prenatal exposure to methadone.

S L Hans1.   

Abstract

This paper has presented evidence of growth and behavioral effects related to prenatal methadone exposure. The data suggest that methadone may have a small direct teratological effect reflected in reduced head circumference, poorer motor coordination, increased body tension, and delayed acquisition of motor milestones in methadone-exposed toddlers. In the sample as a whole, there are no direct effects of methadone exposure on mental development. However, methadone-exposed infants reared in extremely poor environmental circumstances show very delayed mental development. They function more poorly than nonexposed infants reared in such environments and more poorly than methadone-exposed infants reared in more adequate (although still economically poor) environments. This finding is important because it suggests that in the cognitive domain, methadone may not cause a behavioral deficit, but instead create a vulnerability in these children that then makes them more susceptible to impoverished environments. The results from this study indicate that a large subgroup of methadone-exposed children are clearly at risk for poor early intellectual development and that the source of the risk is to a large degree related to environmental factors. These findings suggest that preventive interventions--focused both on enriching the early experiences of such children (e.g., high-quality infant day care) and improving the quality of caregiving provided in the homes--might be particularly effective.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742277     DOI: 10.1111/j.1749-6632.1989.tb21018.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Effects of in utero exposure to street drugs.

Authors: 
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

Review 2.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

3.  Association of prenatal opiate exposure with youth outcomes assessed from infancy through adolescence.

Authors:  Charles R Bauer; John Langer; Brittany Lambert-Brown; Seetha Shankaran; Henrietta S Bada; Barry Lester; Lynn L Lagasse; Toni Whitaker; Jane Hammond
Journal:  J Perinatol       Date:  2020-05-22       Impact factor: 2.521

4.  The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.

Authors:  Allison A Vestal-Laborde; Andrew C Eschenroeder; John W Bigbee; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

Review 5.  Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Authors:  M Kahan; N Sutton
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

6.  Maternal HIV infection, drug use, and growth of uninfected children in their first 3 years.

Authors:  A Ross; G M Raab; J Mok; S Gilkison; B Hamilton; F D Johnstone
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

7.  Recognizing illicit drug use by pregnant women: reports from Oregon birth attendants.

Authors:  L Slutsker; R Smith; G Higginson; D Fleming
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

Review 8.  Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications.

Authors:  Sonia Minnes; Adelaide Lang; Lynn Singer
Journal:  Addict Sci Clin Pract       Date:  2011-07

Review 9.  Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities.

Authors:  Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester
Journal:  Pediatrics       Date:  2019-09       Impact factor: 9.703

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.